Technology
Autoimmunity BioSolutions
Recorded May 27, 2026
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
An immuno-corrective approach for the 25 million people with autoimmune diseases who currently don’t respond to treatment
Oban BioPharma is developing a novel oral treatment class for Type 2 diabetes and obesity that works across multiple pathways involved in metabolism at once
Cycurion delivers a fully cloud-native, hardware-free security architecture that detects, mitigates, and neutralizes threats in real time
4MINDS has launched the only AI platform that allows companies to build industry specific language models that are private
MadSci is developing the world’s first SmartShunt, that uses an intercranial fluid sensor to monitor and control a ICF pressure
Phio Pharmaceuticals (NASDAQ: PHIO) has developed a differentiated, precision approach to treating skin cancer.
Object Pharma is creating a novel, non-systemic neurotoxin platform to help solve today’s mental health crisis
The first company to deliver the true cold coffee experience to homes, hotels, restaurants, and every other place where people enjoy coffee
A proven, proprietary, scalable technology for converting organic waste into the building blocks of Sustainable Aviation Fuel
Myris Therapeutics is revolutionizing the delivery of small molecule cancer therapies with its HiDAR Precision Medicine Platform
IQSTEL (NASDAQ: IQST) reaches over 600 telecom operators with access to approximately 2.3 billion end users around the world.
InCarda Therapeutics has created a new approach to treating A-fib at the moment patients need help most: when an episode begins